Noile-Immune Biotech (TSE:4893) Pre-Tax Income : 円-973.4 Mil (TTM As of Mar. 2024)

Noile-Immune Biotech Pre-Tax Income Chart

Noile-Immune Biotech Quarterly Data
	Dec20	Dec21	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Pre-Tax Income	Get a 7-Day Free Trial				-493.79	-338.55	-16.27	-278.98	-339.57

Competitive Comparison of Noile-Immune Biotech's Pre-Tax Income

For the Biotechnology subindustry, Noile-Immune Biotech's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Noile-Immune Biotech's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Noile-Immune Biotech's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Noile-Immune Biotech's Pre-Tax Income falls into.

Noile-Immune Biotech Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Noile-Immune Biotech's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Noile-Immune Biotech's Pretax Income for the quarter that ended in Mar. 2024 is calculated as

Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-973.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Noile-Immune Biotech  (TSE:4893) Pre-Tax Income Explanation

Noile-Immune Biotech's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

During the past 4 years, Noile-Immune Biotech's highest Pretax Margin was -61.40%. The lowest was -786.86%. And the median was -502.27%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Noile-Immune Biotech Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Noile-Immune Biotech's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Noile-Immune Biotech (TSE:4893) Business Description